Alexium International Group Limited announced that Billy Blackburn has been appointed CEO and Managing Director of Alexium, effective 1 September 2022. In this transition, Dr. Bob Brookins has been appointed Chief Technology Officer (CTO) and will remain an executive director on the Board. Mr. Blackburn has an accomplished background having founded a high-growth technology company specialising in high purity solvents, which was subsequently sold to Nova Molecular.

Mr. Blackburn was appointed Vice President, Business Development at Nova Molecular where he was responsible for substantial revenue growth that included securing major consumer healthcare contracts. More recently, Mr. Blackburn has been the Vice President & Executive Manager with Giant Cement Holdings Inc., which is focused on Renewable Waste Processes.